SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-18-004866
Filing Date
2018-01-31
Accepted
2018-01-31 14:56:10
Documents
1
Group Members
CASEY M. TANSEYDAVID LIDDLEIRWIN FEDERMANJONATHAN D. ROOTPHILIP M. YOUNGPRESIDIO MANAGEMENT GROUP VIII, L.L.C.STEVEN M. KRAUSZUSVP ENTREPRENEUR PARTNERS VIII-A, L.P.USVP ENTREPRENEUR PARTNERS VIII-B, L.P.USVP VIII AFFILIATES FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv483949_sc13ga.htm SC 13G/A 160571
  Complete submission text file 0001144204-18-004866.txt   162425
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2735 SAND HILL ROAD MENLO PARK CA 94025 650 854 9080
US VENTURE PARTNERS VIII L P (Filed by) CIK: 0001225444 (see all company filings)

IRS No.: 912090473 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87757 | Film No.: 18562356
SIC: 2834 Pharmaceutical Preparations